Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
71,364,430
-
Total 13F shares
-
43,247,569
-
Share change
-
-11,335,921
-
Total reported value
-
$106,821,389
-
Put/Call ratio
-
116%
-
Price per share
-
$2.47
-
Number of holders
-
118
-
Value change
-
-$553,553,365
-
Number of buys
-
71
-
Number of sells
-
93
Institutional Holders of Ventyx Biosciences, Inc. - Common Stock, $0.0001 par value per share (VTYX) as of Q4 2023
As of 31 Dec 2023,
Ventyx Biosciences, Inc. - Common Stock, $0.0001 par value per share (VTYX) was held by
118 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
43,247,569 shares.
The largest 10 holders included
CITADEL ADVISORS LLC, BlackRock Inc., VANGUARD GROUP INC, Capital International Investors, Logos Global Management LP, TANG CAPITAL MANAGEMENT LLC, MILLENNIUM MANAGEMENT LLC, MORGAN STANLEY, GOLDMAN SACHS GROUP INC, and Opaleye Management Inc..
This page lists
118
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.